Search for: "Takeda California Inc" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Feb 2008, 11:03 am
Heintz of Porter Wright Morris & Arthur in the firm's Nanotechnology Law Report Podcast of Maniloff's top ten insurance coverage cases of 2007 - Portland attorney David Rossmiller of Dunn Carney in the firm's Insurance Coverage Law Blog Implications of the Amgen-Takeda deal - Management consultant Cliff Mintz of BioInsights Inc. in his Bio Job Blog [read post]
4 Jan 2012, 9:20 am by Ed Wallis
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
5 Jan 2012, 3:10 pm by Ed Wallis
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
17 Feb 2012, 2:00 am by Stephanie Figueroa
NetApp, Inc., where the issue was whether supplemental documents should be produced to comply with post-trial determination pursuant to DGCL Section 220 that books and records must be provided. 2) DealBook: Kodak Can Remove Name From Oscar Venue, Judge Rules – This post shares how lawyers for Eastman Kodak won bankruptcy court permission on Wednesday to cancel the company’s sponsorship agreement with the Los Angeles theater where the Oscars have been held for the last 10… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
2 Apr 2020, 6:30 am by Andrew Hamm
Takeda Pharmaceutical Co. v. [read post]
31 Dec 2014, 5:00 am
  All these actions – many hundreds of plaintiffs – were filed in various California state trial courts. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog)… [read post]
27 Jan 2012, 7:13 am by Ed Wallis
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]